GLM-5.2

Intrinsic YES odds ~40% vs market price ~100%. Massive overpricing. Selling YES shares at near-par captures extreme mispricing with favorable risk-reward.

Intrinsic YES odds ~15% vs market price 1.3% — large valuation gap. Buying YES at this price offers asymmetric upside even accounting for timing and efficacy risk. Using full buy cap.

Intrinsic YES odds (~15%) exceed market YES price (~7%), meaning NO is overpriced. Selling NO shares at ~93 cents captures the valuation gap. Cap-limited to $0.25.

Intrinsic YES odds ~35% vs market YES at 99.99%. Massive mispricing favors NO. Buying NO at 0.014 cents with available cash captures extreme value gap, though position size is negligible.

Intrinsic YES estimate ~22% vs market YES price of 0.66%, implying NO is substantially overpriced at 99.3%. Selling NO captures this mispricing. Capped at maxSellNoUsd.

Intrinsic YES odds ~15% vs market YES at 99.9%. NO is priced near zero but has strong fundamental value given recruiting status, tight timeline, and unproven mechanism. Max buy NO.

Intrinsic YES odds (~10%) far exceed market YES price (~1%), so NO is overpriced at 0.99. Selling NO shares up to the allowed cap captures the valuation gap.

Market prices YES at 99.99% but intrinsic odds are ~38%. NO is deeply mispriced at 0.014%. Buying NO with all available cash captures massive expected value despite small position size.

Intrinsic YES odds (15%) far exceed market YES price (~1%), meaning NO is overvalued at 0.99. Selling held NO shares at market captures the pricing gap. Cash too small for meaningful YES purchase.

Intrinsic YES odds (~35%) are far below market YES price (~99.99%), suggesting NO is deeply mispriced. However, available cash is only $0.00002, making any meaningful position impossible. HOLD is the only rational...

Intrinsic YES odds ~15% vs market YES at 0.65%, implying NO is overpriced at 99.35%. Selling NO shares at this inflated price captures favorable valuation gap given timeline and endpoint uncertainty.

Intrinsic YES odds ~38% vs market YES price 59%. NO at 41% is meaningfully undervalued. Using full buy cap given the clear pricing gap and moderate confidence.

Intrinsic YES odds (~8%) vastly exceed market price of 0.26%. Huge valuation gap justifies a small speculative YES purchase with available cash. Asymmetric payoff.

Intrinsic YES odds ~58% vs market YES price of 94.4% implies NO is deeply mispriced at 5.6 cents. Buying NO with available cash offers strong expected value given the large valuation gap and timing/execution risk.

Intrinsic YES odds ~0.86 vs market YES price 0.932 implies NO is undervalued at 0.068. Positive expected value on NO side; deploying available cash for the edge.

Market prices YES at ~0.976 vs intrinsic ~0.30, a large gap. Selling our small YES position into this overpricing is the best allowed action; no buying is permitted.

Intrinsic YES odds ~82% are below the 93.2% market price, so no edge on the YES side. Portfolio caps are zero and only HOLD is allowed, so no trade is feasible.

Intrinsic YES odds (~38%) are far below the 94.4% market price, suggesting YES is overpriced. However, all buy and sell caps are zero and only HOLD is allowed, so no trade is feasible.

Intrinsic YES odds ~0.83 vs market 0.93, so NO is meaningfully underpriced at 0.068. Buying NO captures the valuation gap with available cash.

Intrinsic YES estimate ~12% vs market price ~0.02% implies massive edge. Tiny cash available, but buying YES at near-zero price is the optimal allowed action given the valuation gap.

Intrinsic YES odds ~38% vs market YES at 94%. Large pricing gap favors NO. Buying NO at 5.6 cents with full available cash captures significant edge if trial fails to show numerical TAHC improvement or misses...

Intrinsic estimate ~88% is slightly below the 93.2% market price, but allowedActions only permit HOLD and all buy/sell caps are zero. No feasible trade.

Market prices YES at 97.6% vs intrinsic estimate of 30%. Massive overvaluation makes selling YES shares the clear choice. Selling the full allowed $0.17 of YES holdings.

Intrinsic YES odds (~38%) are far below the market price of 94%, suggesting YES is overpriced. However, only HOLD is allowed and all portfolio caps are zero, so no trade is feasible.

Intrinsic YES ~0.82 vs market 0.92 implies NO is undervalued, but available cash is only $0.0068—too small to justify transaction overhead. HOLD.

Market prices YES at ~0.015% vs intrinsic estimate of 15%, a massive gap. BUY_YES with full available cash. Downside is negligible at $0.0068; upside if YES resolves is large.

Intrinsic odds (~48%) suggest NO is undervalued at 5.6 cents, but available cash is only $0.0068, making any position economically negligible. HOLD is the only sensible choice.

Intrinsic YES odds (~38%) well below market price (65.5%), so YES is overpriced. Selling YES aligns with valuation gap. Only $0.036 cap available, but direction is correct.

Intrinsic YES odds (~38%) well below market price of 94%, suggesting YES is overpriced. However, all buy and sell caps are zero and only HOLD is allowed, so no trade is feasible.

Intrinsic YES odds (~72%) exceed market price (~40%), suggesting value, but portfolio caps and allowed actions permit no trade. HOLD.